Premature babies diagnosed with bronchopulmonary dysplasia (BPD) face the risk of rehospitalization, delayed brain development, and respiratory problems throughout childhood. No FDA-approved therapies are available for BPD—which is why the new FDA designation for AyuVis's drug candidate, AVR-48, could lead to game-changing impact.
Hayden Blackburn
Chief Operating Officer
TechFW
…on partnering with the Space Alliance Technology Outreach Program, or SATOP, via Fort Worth Report....
TechFW, a nonprofit organization dedicated to fostering innovation and empowering technology entrepreneurs, has named veteran entrepreneur Ryan Brown as its new chief executive officer.
According to TechFW, Brown has extensive experience as an entrepreneur in various industries, including aerospace and defense, and has led company growth and executive leadership within real estate, finance, nonprofits, and events....
Rupa Iyer, vice president of research, innovation, and economic development at Tarleton State University, was program director at the National Science Foundation from 2017 to 2019. [Image: DI Studio; Source Photo: Tarleton State University]